SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 30 filers reported holding SINOVAC BIOTECH LTD in Q3 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $275,000 | – | 36,062 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Verity Asset Management, Inc. | 34,232 | $174,000 | 0.17% |
| Orbimed Advisors | 2,667,500 | $13,551,000 | 0.14% |
| Campbell & CO Investment Adviser LLC | 12,983 | $66,000 | 0.04% |
| Freedom Investment Management, Inc. | 3,662 | $418,000 | 0.04% |
| Pine River Capital Management L.P. | 525,848 | $2,672,000 | 0.03% |
| FIRST MANHATTAN CO. LLC. | 1,032,113 | $5,243,000 | 0.03% |
| FIL Ltd | 1,091,500 | $5,545,000 | 0.02% |
| Renaissance Technologies | 1,292,779 | $6,567,000 | 0.02% |
| UNITED SERVICES AUTOMOBILE ASSOCIATION | 306,388 | $1,556,000 | 0.01% |
| WELLINGTON MANAGEMENT GROUP LLP | 4,583,027 | $23,282,000 | 0.01% |